Biktarvy, formally known as bictegravir sulfate, includes a powerful single-tablet regimen for controlling HIV infection. This formula integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the HIV's ability to replicate within the body, remarkably reducing the viral burden. For man